Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma.

[1]  V. Tagalakis,et al.  Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial. , 2022, Thrombosis research.

[2]  M. Taphoorn,et al.  Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma , 2022, Journal of thrombosis and haemostasis : JTH.

[3]  H. Putter,et al.  Estimation of the Absolute Risk of Cardiovascular Disease and Other Events: Issues With the Use of Multiple Fine-Gray Subdistribution Hazard Models , 2022, Circulation. Cardiovascular quality and outcomes.

[4]  W. Mesker,et al.  Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. , 2021, Thrombosis research.

[5]  G. Raskob,et al.  Abelacimab for Prevention of Venous Thromboembolism. , 2021, The New England journal of medicine.

[6]  L. Soanes,et al.  Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE) , 2021, ESMO open.

[7]  Lara A. Kahale,et al.  American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. , 2021, Blood advances.

[8]  E. Horváth-Puhó,et al.  Venous thromboembolism in cancer patients: a population-based cohort study. , 2020, Blood.

[9]  T. Ozaki,et al.  Symptomatic Venous Thromboembolism in Patients with Malignant Bone and Soft Tissue Tumors: A Prospective Multicenter Cohort Study , 2020, Annals of Surgical Oncology.

[10]  G. Raskob,et al.  Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. , 2020, JAMA.

[11]  Junho Ahn,et al.  Thirty-Day Outcomes after Surgery for Primary Sarcomas of the Extremities: An Analysis of the NSQIP Database , 2020, Journal of oncology.

[12]  N. Fenwick,et al.  International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours – EURO EWING 2012 Protocol , 2019, Trials.

[13]  H. Schreuder,et al.  Bone sarcoma incidence in the Netherlands. , 2019, Cancer epidemiology.

[14]  P. Wells,et al.  Apixaban to Prevent Venous Thromboembolism in Patients with Cancer , 2019, The New England journal of medicine.

[15]  A. Khorana,et al.  Rivaroxaban for Thromboprophylaxis in High‐Risk Ambulatory Patients with Cancer , 2019, The New England journal of medicine.

[16]  P. Metharom,et al.  Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment , 2018, Cancers.

[17]  J. Blay,et al.  High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Lara A. Kahale,et al.  Anticoagulation for people with cancer and central venous catheters. , 2018, The Cochrane database of systematic reviews.

[19]  Peter H Shaw,et al.  A Comparison of Extremity Thrombosis Rates in Adolescent and Young Adult Versus Younger Pediatric Oncology Patients at a Children's Hospital. , 2017, Journal of adolescent and young adult oncology.

[20]  K. S. Hall,et al.  Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial , 2016, The Lancet. Oncology.

[21]  F. Klok,et al.  Current and future perspectives in imaging of venous thromboembolism , 2016, Journal of thrombosis and haemostasis : JTH.

[22]  P. Reitsma,et al.  Tissue factor associates with survival and regulates tumour progression in osteosarcoma , 2016, Thrombosis and Haemostasis.

[23]  S. Schulman,et al.  Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH , 2015, Journal of thrombosis and haemostasis : JTH.

[24]  Sybil A. Klaus,et al.  Hospital-associated venous thromboembolism in children: incidence and clinical characteristics. , 2014, The Journal of pediatrics.

[25]  L. Kremer,et al.  Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters. , 2013, The Cochrane database of systematic reviews.

[26]  F. Klok,et al.  Diagnostic management of acute deep vein thrombosis and pulmonary embolism , 2013, Journal of thrombosis and haemostasis : JTH.

[27]  T. Choueiri,et al.  Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  S. Vesely,et al.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[29]  M. Verduijn,et al.  The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  D. Roth,et al.  Patient death as a censoring event or competing risk event in models of nursing home placement , 2010, Statistics in medicine.

[31]  T. Niazi,et al.  Osteosarcoma presenting as hemorrhagic cerebellar metastasis , 2009, Child's Nervous System.

[32]  Gary H Lyman,et al.  Development and validation of a predictive model for chemotherapy-associated thrombosis. , 2008, Blood.

[33]  David M. Thomas,et al.  The distinctive biology of cancer in adolescents and young adults , 2008, Nature Reviews Cancer.

[34]  Anthony K. C. Chan,et al.  Thromboembolism in children with sarcoma , 2007, Pediatric blood & cancer.

[35]  L. Helman,et al.  Thromboembolic events in children and young adults with pediatric sarcoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  A. McCaskie,et al.  Venous thromboembolism in patients with primary bone or soft-tissue sarcomas. , 2007, The Journal of bone and joint surgery. American volume.

[37]  M. Levine,et al.  Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  G. Agnelli,et al.  Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  S. Abraham,et al.  Hemorrhagic shock due to intrathoracic rupture of an osteosarcoma of the rib. , 2001, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[40]  K. Antman,et al.  Sarcomas of soft tissue and bone , 1991, Cancer.